Purpose: To analyze the role and translational potential for hypermethylation of CpG islands and shores in the regulation of small RNAs within urothelial cell carcinoma (UCC). To examine microRNAs (miR) and mirtrons, a new class of RNA located within gene introns and processed in a Drosha-independent manner.
Introduction
Urothelial cell carcinoma (UCC) of the bladder is the fourth commonest male malignancy, third most prevalent and one of the most expensive cancers in the United States (1) . Most UCC are low-grade tumors that are characterized by mutations of FGFR3 and relative genetic and epigenetic stability. These tumors frequently recur within the bladder, but rarely progress to invasion. High-grade UCC have numerous genetic events and are characterized by loss of the p53 function (2, 3) . These tumors may be diagnosed while confined within the urothelium, but frequently progress to muscle invasion. High-grade tumors have frequent CpG island hypermethylation and this can be used to identify progression risk (4, 5) .
MicroRNAs (miR) are short noncoding RNAs that posttranscriptionally regulate gene expression and are implicated in carcinogenesis (6) . We have recently observed differential expression of numerous miRs in malignant and normal urothelium (7) . These alterations may arise from either genetic or epigenetic events (6, 8) . Although it is known that CpG island hypermethylation is associated with tumor-suppressor gene silencing, this alteration is not always disease specific (9) . Epigenome-wide profiling has revealed that many regions with cancer-specific differential methylation are located adjacent to CpG islands in regions of less dense CpG dinucleotides, termed CpG shores (10) . Hypermethylation of these shores appears important in the regulation of gene expression.
Little is known about epigenetic control of miR expression in UCC. Reports in other malignancies have found aberrant CpG island hypermethylation is associated with miR silencing (11) (12) (13) . We hypothesized that altered miR expression in UCC may arise from epigenetic mechanisms and that changes occur in both CpG islands and shores. We were also interested in a new class of small RNA, termed mirtrons (14, 15) . These are transcribed from short introns and processed independently of Drosha. We hypothesized their location within gene coding RNAs may make them susceptible to epigenetic silencing. To test these hypotheses we examined the methyl status of 700 small RNAs and mapped their proximity to both CpG islands and differentially methylated shore regions.
Materials and Methods

Patients and samples
We investigated 359 patient samples and 4 urothelial cell lines representing low-grade (RT4), high-grade (RT112), and invasive (EJ/T24) UCC, and normal human urothelium (NHU; ref. 7, 16) . To explore the frequency and translational roles for epigenetic miR silencing we studied malignant and normal urothelial tissues from 238 patients (Table 1) and 121 freshly voided urinary samples (cohort 3,  Table 1 ; detailed in Miah and colleagues, submitted manuscript). Urinary controls included those without disease, those with symptoms suggestive of UCC, urinary stones, and benign prostatic enlargement. Patients with hematuria or uropathology had UCC excluded by cystoscopy and urinary tract imaging (n ¼ 50/53, 94%). Ethics committee approval was obtained prior to opening this study and patients recruited following informed consent.
RNA expression and methylation of CpG dinucleotides and adjacent histones
To determine CpG hypermethylation we compared miR and mirtron expression in cell lines using microarrays before and after DNA methyltransferase inhibition with 5-azacytdine. To determine methylation of individual cytosines we used bisulfite sequencing of CpG regions adjacent to miRs (methods detailed in Supplementary Material and ref. 17) . We used commercial microarrays containing probes to 865 human small RNAs (V2 miRNA microarray; Agilent; GEO Platform: GPL7731) in triplicate for each cell line and treatment. Expression of individual miRs was measured by real-time RTPCR (Applied Biosystems) as previously described (7) . For DNA methyltransferase inhibition we grew cells for 5 to 7 days in 2 mmol/L 5-azacytidine (Sigma).
We selected RNAs for analysis by using bisulfite sequencing from those in which 5-azacytdine induced altered expression and were adjacent to CpG islands and differentially methylated regions (DMR), from miRs found to be methylated in other tumors, and from RNAs located adjacent to both CpG islands and DMRs (12, 13, 18) . Briefly, target CpG regions were amplified by using bisulfite-specific PCR, the products cleaned and cloned into Escherichia coli before sequencing (detailed in ref. 19 ). Histone modification adjacent to CpG regions was determined by chromatin immunoprecipitation with antibodies to histone-3 lysine-9 trimethylation (Millipore) and a nonspecific control (rabbit IgG; Santa Cruz Biotechnology).
Methylation in primary tumors and phenotypic effects
Clinicopathologic associations with methylation were examined in 176 microdissected samples by using methyl-specific PCR (Supplementary Methods; Supplementary Table 1 ). Products were visualized in a 3% agarose gel and compared with positive (universally methylated DNA; Invitrogen) and negative controls (4) . The regulation of cell proliferation by RNAs susceptible to epigenetic silencing was evaluated by the MTT assay. Six replicates for each experiment were conducted in NHU cells reverse transfected with specific anti-miR molecules (50 nmol/L; Ambion) and a scrambled RNA sequence (negative control). Cells were transfected once by using siPORT NeoFX reagent at the start of the experiment (as detailed in ref. 7) . Successful knockdown was confirmed with QRTPCR.
Bioinformatics and statistical analyses
To examine CpG proximity and to annotate our microarray we combined the location of all small RNAs on our microarray (n ¼ 865), all human CpG islands (n ¼ 28,227) more than 200 bp in length (20) , and the 19,086 DMRs recently identified (10)-of which 73% were CpG shoresinto a single database. We incorporated the miRGen database describing the relationship with coding genes for 443 miRs (21) . We carried out a similar analysis for 36,953 coding genes.
RNA expression was compared between treated and untreated matching cell lines by microarray fluorescence values extracted by using feature selection software (Agilent). We compared CpG methylation and RNA expression with clinicopathologic features by c 2 or Kendall-tau test for discrete variables, ANOVA or Mann-Whitney U test for continuous data, and the log-rank test with Kaplan-Meier plots for outcome. Tumor progression was defined as pathologic, radiological, or clinical evidence of an increase in tumor stage and measured from the time of surgery. Individual miR expression was determined by real-time
Translational Relevance
Altered microRNA (miR) expression is common in urothelial cell carcinoma (UCC) and reflects genetic events within tumors. Here we identify a cohort of miRs and mirtons, a new class of small RNAs, which are susceptible to epigenetic silencing. We show DNA hypermethylation in 35 CpG regions adjacent to 20 miRs. We find miRs-152/1224 have prognostic and diagnostic value in UCC. We show hypermethylation of CpG shore regions and find it more common and potentially disease specific than corresponding CpG islands. Finally we identify that mirtrons are particularly susceptible to epigenetic silencing in cancer. These data reveal insights into disease biology and suggest epigenetically silenced small RNAs are potential therapeutic targets and could be used as biomarkers in UCC.
PCR and quantified relative to RNU48 (DCt ¼ Ct miR À Ct RNU48 ). All statistical analyses were 2-sided and conducted in SPSS (Vsn. 14.0 SPSS Inc.; ILL) by using P < 0.05 for significance.
Results
MicroRNA genes, mirtrons, coding genes, and CpG proximity
We were able to map 705 small RNAs to CpG island and DMR proximity. We found 155 (22%) and 263 (37%) of these were located within 3 and 10 kb of a CpG island, respectively (Supplementary Fig. 1 ; http://www.shef.ac.uk/ medicine/oncology/units/urology/data.html). This distribution is similar to that for coding RNA genes [n ¼ 7,494 (25%) and n ¼ 12,409 (42%), respectively, c 2 P > 2 P ¼ 0.002). In total, 15 of 38 (40%) exonic and UTR miRs were close to both CpG structures. We mapped 13 of 19 known mirtrons to chromosomal location (22) . The majority were close to CpG islands [<10 kb, n ¼ 9 of 13 (69%)], but only 3 of 13 (23%) were near a DMR. Thus Table 2 ). Hierarchical clustering revealed cell lines grouped according to identity rather than 5-azacytidine treatment ( Supplementary Fig. 2 ). In total, 195 miRs increased and 73 decreased the frequency of their expression with 5-azacytidine. MiRs with altered expression were not related to CpG/DMR/coding gene proximity (Kendall-tau test, P > 0.2). Of the 268 miRs with altered expression, 75 (28%) and 124 (46%) were within 3 and 10 kb of a CpG island, and 41(15%) and 86 (32%) within 3 kb and 10 kb of a DMR. In total, 27 (11%) and 79 (29%) miRs were within 3 kb and 10 kb of both a CpG regions. To determine the relationship between expression and DNA methylation we selected 20 miRs for analysis from those with altered expression after 5-azacytidine that were close to CpG islands and DMRs, and mostly expressed in NHU cells (Supplementary Table 2 ). We included miRs-9/34b/ 152 as they have previously been reported aberrantly hypermethylated in cancer and a sample of those close to both DMRs and CpG islands (12, 13) .
Methyl status of CpG islands and DMRs
Bisulfite sequencing revealed hypermethylation of many CpG islands and DMRs (Table 2 ; Fig. 1A ). For RNAs adjacent to only CpG islands, we usually found hypermethylation in one or more cell line. For miRs-9-3/152/ 516a/551a hypermethylation appeared tumor-specific. In miRs close to both CpG islands and DMRs, we saw 2 patterns of methylation. For most (9 of 13 RNAs) we found the DMR had more extensive and was more frequently hypermethylated than the corresponding island. For the remaining RNAs (4 of 13) there was equal hypermethylation of both regions. In 3 RNAs (miR-210/212/1227) the difference in hypermethylation between DMR and CpG island was absolute.
To compare RNA expression and DNA methylation directly, we measured these for miR-1224 in EJ before and after 5-azacytdine ( Supplementary Fig. 3 ). We chose this cell line as its showed absolute hypermethylation with sequencing ( Fig. 1) and miR upregulation by using microarrays. We found that 5-azacytidine reduced DNA methylation levels in both the CpG island and shore (mean 1.0 to mean 0.46) and this was associated with a 4-fold increase in miR-1224-3p expression [mean DDCt 4.21 (Nb. miR-1224-3p is the dominant species from the miR-1224 gene)]. We then compared methylation and expression in 20 UCC cases from cohort 1. Once again we found the presence of hypermethylation was significantly associated with low RNA expression (ANOVA P < 0.006; Supplementary Fig. 3D ).
We expected methyl patterns to be disease specific, but detected CpG hypermethylation in NHU cells. As NHU cells are adapted to in vitro growth and fail to grow in the presence of 5-azacytidine, they may have acquired epigenetic alterations in their transition from NHU (23) . We performed bisulfite sequencing on 18 CpG islands and DMRs in corresponding pairs of frozen urothelial biopsies (taken at harvesting) and culture-adapted NHU cells (Supplementary Table 3 ). For most loci the paired samples had identical methyl profiles. For miR-149 there were 2 pairs in which the NHU cells were enriched for hypermethylation, when compared with the frozen counterparts (samples #2, #3, Supplementary Fig. 4 ).
Histone methylation adjacent to CpG islands and DMRs
Histone-3 lysine-9 trimethylation is associated with hypermethylation of the adjacent DNA. To date, most investigators have described this association in CpG islands. We were interested to see whether the association persisted in the less dense DMR regions (i.e., CpG shores). Using chromatin immunoprecipitation and PCR we detected this modification in both CpG islands and DMRs. Histone methylation often matched the corresponding DNA methyl status ( Fig. 1B ; densitometry in Supplementary Fig. 5 ). For example, the CpG islands around miRs-149/212 are unmethylated at the DNA and for histone-3 lysine-9, in contrast to the adjacent DMR.
Cell phenotype and RNA expression
We previously profiled the expression of 365 miRs in 52 UCC (cohort 1; ref. 7; data deposited: http://www.shef.ac. uk/medicine/oncology/units/urology/data.html). We analyzed progression-free survival in these 52 patients by using 13 of the 20 identified miRs (Nb. 7 miRs not present on the TLDA array). Normalized miR expression was dichotomized around the mean and normal expression determined from 10 normal urothelial samples (patients without UCC). We detected higher progression rates with reduced expression for miRs-152/193a/503 (log-rank P < 0.05; Supplementary Fig. 6 ) and nonsignificant trends toward higher progression rates with reduced expression for miRs-9/24/ 126/34a/210 (P < 0.2), compared with tumors with normal expression. The low sample size may have prevented sufficient analysis of these loci. Multivariate analysis using clinicopathologic details and miR-152/193a/503 expression revealed that stage (Cox OR ¼ 2.0; 95% CI, 1.1-3.7) and miR-152 expression (Cox OR ¼ 0.8; 95% CI, 0.7-0.9) were the factors most associated with progression.
We chose miR-152 and miR-1224 for further analysis. MiR-1224 was absent on the TLDA array but appeared differentially methylated in the urothelium and across the island/shore regions. To examine a functional role for these we measured proliferation following miR knockdown. MTT assays in NHU cells with loss of miR-152 and miR-1224 revealed generally higher proliferation rates when compared with control cells. This reached significance at 14 days (Supplementary Fig. 7A ; ANOVA P < 0.001). Quantification of miR knockdown revealed that RNA expression returned to pretreatment levels by day 5 ( Supplementary Fig. 7B ), suggesting that the mRNA changes affecting proliferation occur within the first 5 days and are not dependant on continuous miR suppression.
Mirtron and microRNA hypermethylation in bladder tumors
Hypermethylation at the CpG island and DMR adjacent to miR-1224 and the CpG island for miR-152 was analyzed by using DNA from cohort 2. Bisulfite conversion was determined by using primers to the unmethylated CpG islands (Fig. 2) . For each locus, hypermethylation was significantly more common in malignant than NHU (c 2 P < 0.032; Table 3 ). The extent of methylation increased with worsening differentiation and advancing stage. This increase reached statistical significance for all relationships except miR-1224 CpG island and tumor grade (c 2 P ¼ 0.43). When compared, hypermethylation at the DMR for miR-1224 appeared pathologically more specific than for the island (Table 3 ). For each locus there was more progression to advanced disease in tumors with miR hypermethylation, than those without this change (log-rank P < 0.003, Fig. 2B ). The DMR (CpG shore) at miR-1224 appeared more predictive than the CpG island. Multivariate analysis including clinicopathologic details revealed that miR-1224 DMR hypermethylation (Cox OR ¼ 2.5; 95% CI, 1.3-5.0; P ¼ 0.006), grade (Cox OR ¼ 1.7; 95% CI, 1.1-2.7; P ¼ 0.012), and stage (Cox OR ¼ 1.6; 95% CI, 1.1-2.3; P ¼ 0.007) were independently associated with tumor progression. Concordant methylation of the DMR and island at miR-1224 was found in 104 of 153 (68%) tumors (r ¼ 0.34, P < 0.0001).
Urinary mirtron and microRNA expression
We compared the expression of epigentically regulated RNAs in cells from 121 urine samples (68 UCC cases and 53 controls). We measured the expression by using commercial assays and normalized to RNU48 (methods detailed in Miah and colleagues, submitted manuscript). Methylation at individual cytosines is illustrated as a percentage from 5 cloned products. The CpG island (has more CpG dinucleotides and so appears larger than the shore) is closer to the gene start site than the shore for all illustrated miRs except miR193a. B, chromatin immunoprecipitation PCR agarose images (displayed cropped for clarity) reveal the presence of trimethylated histone-3 lysine-9 for various CpG islands and shores. For each target PCR the input DNA (i.e., sonicated DNA removed prior to immunoprecipitation) is shown next to the DNA precipitated with an antibody to H3K9-3m and a nonspecific control (rabbit IgG antibody).
We analyzed miRs-152/212/328 and miR-1224-3p, and found each was detected more frequently and with a higher expression in urinary samples from cancer-free controls than in patients with UCC (ANOVA P < 0.016; Table 4 ; Fig. 2C ). Low expression of miRs-152/328/1224 were most diagnostic of UCC (concordance indices, 0.80-0.84). We dichotomized each RNA around its mean and scored samples according to the number of abnormally expressed RNAs. The combination of low miRs-152/328/1224-3p was most concordant with UCC (Concordan index, 0.86; 95% CI 0.80-0.93; Fig. 2D ).
Discussion
Approximately one third of miRs are close to CpG islands, approximately one fourth are close to CpG shores, and approximately one fifth are close to both structures. The likelihood of proximity to these regions increases to approximately half for miRs located within coding gene exons and UTRs, and further still for mirtrons (70% are close to CpG islands). Our systematic analysis has revealed the clustering found for many miRs creates potential hotspots of epigenetic deregulation where CpG methylation at single locus may affect numerous miRs. For example, we identified hypermethylation of the CpG shore and island at miR-24-1. This miR is clustered with miR-23b and miR-27b around this CpG island on Chr 9q22.32 within the 3 0 UTR of Aminopeptidase O and upstream of FANCC. Loss of 9q22 occurs in 50% of UCC (24) and targets include PTCH, TGFBR1, TSC1, and DBCCR1. MiR-24 is known to have a p53-independent antiproliferative effect (25) . We previously observed correlated downregulation of these 3 Supplementary Fig. 8A ). There are other such potential epigenetic hotspots, including the 6 miRs around within C13orf25 at 13q31.3 (correlated expression illustrated in Supplementary Fig. 8B ), miRs-16-2/15b within SMC4 at 3q26, miRs-647/1914 with UCKL1 at 20q13.33, and miRs-449a/449b within CDC20 at 5q11.
miRs in UCC (
Our experiments focused on CpG methylation around small RNAs and identified a high frequency of DNA hypermethylation among selected small RNAs. We confirmed reports of aberrant hypermethylation in other tumors for miRs-34a/126/149/152/193a/200b/210/ 212/503/516a and for miRs-9-1/9-2/9-3 (26, 27) . We identified new miRs susceptible to epigenetic silencing including miRs-24-1/328/551a and mirtrons miRs-1224/1226/1227/1229. These data are interesting as they reveal that epigenetic silencing may be generic to cancer or subtype specific. Hypermethylation of miRs-9/34/200 has been reported in UCC, colon, breast, lung, and kidney cancers (12, (26) (27) (28) , suggesting they control events generic to malignancy. Indeed the combination of miR-9 and miR- 200 has recently been proposed as prognostic signature for cervical cancer (29) . In contrast, hypermethylation for miRs-24-1/126/212 appears specific to UCC and colon cancer (12) , as this does not occur in other tumors (27) . No previous reports have identified hypermethylation of miRs-328/551a/1224/1226/1227/1229 in cancer. This may be due to disease specificity (possibly for miR-328/ 551a) or that these targets were not analyzed previously.
MiRs-1224/1226/1227/1229 belong to a recently identified family of small RNAs known as mirtons (14, 15) . These differ from miRs in their genomic structure and processing. Mirtron genes are transcribed as hairpins, spliced, and debranched in a Drosha-independent manner (30) . Their genomic structure consists of short introns that use splicing to avoid Drosha cleavage. Following nuclear export, mirtrons are integrated into the canonical miR pathway and cleaved by Dicer before incorporation into the RNA-silencing complex (14, 15) . Mirtron hairpins preferentially select the 3 0 transcript for mRNA targeting, in contrast to the 5 0 predominance for miRs. Each mirtron is located within a coding gene intron (Table 2 ) making them interesting from the genomic perspective and often located close to CpG islands. The mirtrons we identified are found within regions implicated in human cancer and in UCC specifically. MiR-1224 is located at 3q27.1 within a CpG island in intron 18 of VWA5B2 (von Willebrand factor A domain containing 5B2). This is close to the p63 tumor suppressor gene that is downregulated and associated with a poor prognosis in UCC (31) . MiR-1226 is within the putative RNA helicase DHX30 at 3p21.1, a fragile site deleted in lung and other tumors (32, 33) . Deletion of this region is associated with smoking and asbestos exposure suggesting direct carcinogen targeting (34) . MiR-1227 is located at 19p13.3, close to STK11 the gene implicated in Peutz-Jeghers syndrome, and within a region deleted in colon cancer (35) . MiR-1229 is found within a glycotransferase (MGAT4B) at 5q35.5. This region is deleted in a small fraction of UCC but is a common fragile site in lung cancer (33, 36) . Epigenetic silencing of MGAT4B is likely in cancer as down regulation occurs during the development of drug resistance (37) and can be reversed by 5-azacytidine (38) . Interestingly, comparative genomic hybridization analysis of lung tumors identified 3 of our 4 mirtron loci and that for miR-1225, as fragile hotspots deleted within the disease (33). We selected miR-152 and miR-1224 for prognostic and diagnostic evaluation. The expression of both was associated with the presence and phenotype of UCC. This suggests they play roles in urothelial carcinogenesis and the need for functional studies to evaluate mRNA targets. When compared it appeared that methylation of the CpG shore for miR-1224 was more prognostic and more closely associated with phenotype than for the island. This supported cell line observations, where CpG shore methylation was more common and extensive than for islands. This was especially true for mirtrons. These observations support the role for CpG shore hypermethylation in human cancer and could potentially lead to more disease-specific diagnostic tests. Studies of CpG island hypermethylation around tumor suppressor genes report age related changes that affect diagnostic test specificity (9) . It should be noted that conflicting observations were seen with respect to cancer specificity and CpG island and shore methylation. Although for miR-1224 the shore appeared more cancer specific than the island, the reverse was true for miR-9-1/-2. Further studies to evaluated CpG shore regions are needed in UCC.
In conclusion, we have identified a cohort of miRs and mirtrons that are susceptible to epigenetic silencing in cancer. We have shown the presence of CpG hypermethylation for many of these in UCC and found that certain CpG shore alterations appear more disease specific than for the corresponding island.
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